Prospective Study to Assess Usage, Adherence, Effectiveness of Cabotegravir LA for Pre-Exposure Prophylaxis in the United States in the OPERA Cohort (219844)

17/05/2024
05/12/2025
EU PAS number:
EUPAS1000000165
Study
Ongoing
Documents
Study protocol
Initial protocol
English (768.61 KB - PDF) View document
Study results
Study report
Other information